Sean Dodge
Stock Analyst at RBC Capital
(2.37)
# 2,309
Out of 4,670 analysts
149
Total ratings
42.4%
Success rate
-0.47%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGL agilon health | Reiterates: Outperform | $3 | $1.89 | +58.73% | 6 | Nov 19, 2024 | |
| OPRX OptimizeRx | Maintains: Outperform | $14 → $7 | $4.87 | +43.74% | 10 | Nov 14, 2024 | |
| EVH Evolent Health | Reiterates: Outperform | $20 | $11.25 | +77.78% | 8 | Nov 12, 2024 | |
| WAY Waystar Holding | Maintains: Outperform | $31 → $34 | $31.25 | +8.80% | 2 | Nov 7, 2024 | |
| HCAT Health Catalyst | Maintains: Sector Perform | $8 → $9 | $8.13 | +10.70% | 8 | Nov 7, 2024 | |
| CDMO Avid Bioservices | Downgrades: Sector Perform | $12 → $13 | $12.30 | +1.63% | 14 | Nov 7, 2024 | |
| IQV IQVIA Holdings | Reiterates: Outperform | $270 | $201.82 | +33.78% | 3 | Nov 5, 2024 | |
| TDOC Teladoc Health | Maintains: Outperform | $9 → $10 | $10.62 | -5.84% | 15 | Oct 9, 2024 | |
| PHR Phreesia | Reiterates: Sector Perform | $23 | $19.87 | +15.75% | 14 | Sep 27, 2024 | |
| TBRG TruBridge | Reiterates: Outperform | $14 | $16.54 | -15.36% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $92 | $104.25 | -11.75% | 11 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $4.90 | +104.08% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $21.56 | +29.87% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $17 | $12.82 | +32.61% | 9 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $14 | $11.68 | +19.86% | 13 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $64 | $60.98 | +4.13% | 16 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $174.81 | -81.12% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $990 → $180 | $1.82 | +9,790.11% | 2 | Mar 9, 2022 |
agilon health
Nov 19, 2024
Reiterates: Outperform
Price Target: $3
Current: $1.89
Upside: +58.73%
OptimizeRx
Nov 14, 2024
Maintains: Outperform
Price Target: $14 → $7
Current: $4.87
Upside: +43.74%
Evolent Health
Nov 12, 2024
Reiterates: Outperform
Price Target: $20
Current: $11.25
Upside: +77.78%
Waystar Holding
Nov 7, 2024
Maintains: Outperform
Price Target: $31 → $34
Current: $31.25
Upside: +8.80%
Health Catalyst
Nov 7, 2024
Maintains: Sector Perform
Price Target: $8 → $9
Current: $8.13
Upside: +10.70%
Avid Bioservices
Nov 7, 2024
Downgrades: Sector Perform
Price Target: $12 → $13
Current: $12.30
Upside: +1.63%
IQVIA Holdings
Nov 5, 2024
Reiterates: Outperform
Price Target: $270
Current: $201.82
Upside: +33.78%
Teladoc Health
Oct 9, 2024
Maintains: Outperform
Price Target: $9 → $10
Current: $10.62
Upside: -5.84%
Phreesia
Sep 27, 2024
Reiterates: Sector Perform
Price Target: $23
Current: $19.87
Upside: +15.75%
TruBridge
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $16.54
Upside: -15.36%
Sep 4, 2024
Reiterates: Outperform
Price Target: $92
Current: $104.25
Upside: -11.75%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $4.90
Upside: +104.08%
Aug 14, 2024
Reiterates: Outperform
Price Target: $28
Current: $21.56
Upside: +29.87%
Aug 6, 2024
Reiterates: Outperform
Price Target: $17
Current: $12.82
Upside: +32.61%
Jul 25, 2024
Maintains: Outperform
Price Target: $15 → $14
Current: $11.68
Upside: +19.86%
Jul 11, 2024
Reiterates: Sector Perform
Price Target: $64
Current: $60.98
Upside: +4.13%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $174.81
Upside: -81.12%
Mar 9, 2022
Maintains: Sector Perform
Price Target: $990 → $180
Current: $1.82
Upside: +9,790.11%